1497 studies found for:    TNF
Show Display Options
Rank Status Study
21 Unknown  Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
Condition: Rheumatoid Arthritis
22 Not yet recruiting Immune Function in Offsprings of Females With Inflammatory Bowel Disease (IBD) Treated With Anti-TNF Medications During Pregnancy
Condition: Inflammatory Bowel Disease
23 Completed 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: anti-TNF
24 Completed Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Conditions: Hepatitis B;   Hepatocellular Carcinoma;   Chronic Liver Disease
Intervention: Genetic: Polymorphism of IL-1 beta and TNF-alpha
25 Active, not recruiting Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients
Condition: Crohn's Disease
Interventions: Biological: TNF Kinoid;   Biological: WFI
26 Completed L19TNFα in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Colorectal Cancer
Intervention: Drug: L19TNFa
27 Completed Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
Conditions: Recurrent Melanoma;   Stage III Melanoma
Interventions: Drug: isolated limb perfusion;   Drug: melphalan;   Biological: recombinant tumor necrosis factor family protein;   Other: pharmacological study;   Other: laboratory biomarker analysis
28 Recruiting Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Ulcerative Colitis;   Crohn's Disease;   Indeterminate Colitis
29 Active, not recruiting Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.
Conditions: Psoriasis Vulgaris;   Metabolic Syndrome
30 Recruiting Escape II Myocardium
Condition: Rheumatoid Arthritis
Interventions: Drug: Triple Therapy;   Drug: TNF inhibitors
31 Recruiting Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Conditions: Chronic Hepatitis B;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Juvenile Idiopathic Arthritis
Interventions: Drug: Entecavir;   Drug: Placebo
32 Unknown  The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
Conditions: Rheumatoid Arthritis;   Crohn's Disease;   Ankylosing Spondylitis;   Psoriasis
Intervention: Drug: TNF-alpha antagonists
33 Completed Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Conditions: Coccidioidomycosis;   Rheumatoid Arthritis
34 Unknown  Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
Intervention: Drug: Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab)
35 Completed A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Tumor Necrosis Factor soluble receptor-immunoadhesin complex
36 Completed Endotoxin & Cytokines. Do Protein Loss and Metabolic Effects Depend on Central Nervous System (CNS) Activation of Stress Hormones or on Local Mechanisms in Muscle and Fat?
Conditions: Inflammation;   Glucose Metabolism Disorders
Interventions: Biological: TNF-alpha;   Biological: Endotoxin
37 Recruiting Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
Interventions: Drug: Pred + Meth;   Drug: Anti TNF + Meth
38 Completed TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: colloidal gold-bound tumor necrosis factor;   Other: pharmacological study
39 Completed Study of TNF-Antagonism in Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Drug: Etanercept;   Drug: Placebo
40 Completed Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS)
Condition: TNF-receptor Associated Periodic Syndromes (TRAPS)
Intervention: Drug: ACZ885

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years